100 relevant articles · classified by Haiku 4.5 · ingested daily
Parakeet Health raises a $10M Series A led by Canvas Ventures for its conversational agentic platform for healthcare.

Merck pays $400M for global rights to SciBrunch's KRAS G12D inhibitor cancer drug candidate.

Intuitive receives CE mark approval for its surgical robot in cardiac applications, renewing its push into cardiovascular surgery.

FDA nominee Overton tells Senate she will follow the law on vaccines and work to accelerate early drug research.

Oracle Health embeds a clinical AI agent directly in its EHR for nurses, eliminating cross-tool switching.

Oura Health files for IPO, seeking to raise up to $2.2B.

Cognita Imaging wins an FDA contract to develop a method for evaluating LLM-generated radiology reports.

A JAMA study finds 12M Americans lack broadband access needed for telehealth, disproportionately in rural areas.

A report warns that agentic AI deployment in healthcare is outpacing security and governance frameworks, risking patient safety.

Beta Bionics receives FDA clearance for its first insulin patch pump, entering the market against Insulet.

Inspiren raises $70M in Series C led by NewView Capital for its AI-powered senior living platform using ambient sensors and computer vision for fall prediction.

Nutromics earns FDA breakthrough device designation for a wearable patch that monitors vancomycin levels in real time, replacing periodic blood draws.

ARPA-H awards $62.7M to Tempus AI and Updoc to build an agentic AI system for heart failure management.

Researchers develop a wireless smart microneedle device for connected, personalized pain management.

Oracle Health executives subpoenaed after VA EHR contract ballooned from $10B to $27B.

Selio Medical secures FDA clearance for a hydrogel device that seals CT-guided lung biopsy punctures, preventing pneumothorax in the 800,000+ annual U.S. procedures.

Thyme Care raises $125M in Series E led by Morgan Health and launches a new oncology parent entity.

Teva's IL-15 antibody prevents intestinal damage in celiac disease patients during a mid-stage gluten challenge trial.

Abbott's TactiFlex Duo catheter combining PFA and RF energy shows sustained efficacy at one year in complex atrial fibrillation cases, supporting an FDA submission.

Opinion piece argues that layering AI onto outdated healthcare workflows won't drive enterprise transformation without redesigning care delivery itself.

Stryker acquires ZuriMED for rotator cuff repair augmentation technology.

MiniMed submits a tubeless insulin pump for FDA clearance, ahead of a fully closed-loop system launch.

Hims & Hers launches GLP-1 weight-loss drugs and men's health treatments in Australia, expanding beyond the U.S.

RADIN Health's PACS and dictation AI adopted by Northern Oklahoma Radiology Physicians to expand teleradiology services.

Boston Scientific's manufacturing and order fulfillment disrupted by a cyberattack with no timeline for restoration.

Abbott wins CE mark for a new left atrial appendage closure device, competing with Boston Scientific in the stroke-prevention market.

Sword Health agrees to acquire Headspace in an all-cash deal expected to close next month.

Abbott receives FDA clearance for the Libre Duo 10 Day, a sensor that measures both glucose and ketones.

Expressable joins Amazon's Health Benefits Connector to offer virtual speech therapy via insurance.

Roche licenses Hanmi's clinical-stage obesity peptide that targets muscle CRF2 receptors to reduce fat while preserving muscle mass.

Sondermind and Limbic join the FDA's TEMPO pilot to evaluate digital health devices for anxiety and depression.

FDA publishes best-practice guidance on using wearables and digital health technologies in clinical trials, emphasizing patient-relevant outcomes and device validation.

Stryker, Medtronic, and Abbott are among medtech firms that have disclosed cyberattacks so far in 2026.

R1 acquires Humata to apply AI toward automating prior-authorization workflows in revenue-cycle management.

Boulevard Bio launches with Deerfield backing and anti-CD40 antibody for autoimmune kidney disease.

Ransomware attack at Unlimited Technology Systems exposes 3.8M patient records, the second-largest healthcare breach reported to HHS this year.

NOCD plans nationwide expansion of its virtual intensive outpatient program for severe OCD.

An analysis argues kidney care investments have failed to reduce hospital costs because they target the wrong interventions.

IMDC launches a clinical AI certification program amid rising attention to digital healthcare.

A federal court rejects an antitrust challenge to GLP-1 drug distribution deals, preserving existing pharmaceutical supply arrangements.

Analysis argues Epic's AI integrations are building an increasing moat in the EHR market.
Doximity raises revenue outlook on clinical AI adoption, shares up 31%.

An AI framework unifies tumor segmentation, grading, and malignancy detection in MRI scans.

Infrastructure gaps — unreliable power and internet — hinder AI adoption in rural health facilities.

Africa Health commits to a 10-point digital health pledge at ILF 2026.

The Lagos State government announces a push to integrate AI and health data to improve healthcare delivery.

An AI tool identifies previously undetectable heart dysfunction from standard ECG readings.

Nsight Health reports blood pressure and glucose improvements in monitored chronic disease patients.

AI drug discovery has raised $8.9B but produced zero FDA-approved drugs, raising doubts about the hype cycle.

Doximity reports first quarter earnings results.

Pathos AI inks two cancer drug deals — one with Alphamab for a bispecific ADC and one with AstraZeneca for a protein degrader.

Control Bionics receives FDA listing for its NeuroStrip neuromuscular monitoring device.

Control Bionics receives FDA registration for its NeuroStrip wearable platform.
Yonsei researchers are building an AI platform to speed up therapy and vaccine development for emerging infectious diseases.

Receptor.AI and Sethera partner to use AI for peptide drug discovery.

Throne Science closes a $10M Series A for its AI-powered toilet sensor that tracks gut health and hydration.

Included Health acquires Firefly Health to expand its alternative health plan offering for employers.

Included Health acquires Firefly Health to differentiate in the crowded employee benefits market.

Aidoc submits a generative AI radiology report-drafting system to the FDA for clearance.

Tāmaki Health begins trialing an AI-powered coaching app.

CARPL.ai raises $10M in Series A funding led by IFC.

Generative AI is used to improve ultrasound image quality and interpretation.

CARPL.ai raises a $10M Series A led by IFC for radiology AI platform.

CARPL.ai raises $10 million from the International Finance Corporation.

ONC publishes USCDI Version 7, adding 30 new data elements to the nationwide interoperability standard.

An inherited retinal disease trial highlights how AI diagnostic evidence can reshape clinical trial design and regulatory thinking.

India's Union Health Minister launches Aarogya Setu 2.0 and new digital health initiatives.

Neko Health raises $700M to fund its expansion into the US market.

Hims & Hers shares fall as Amazon intensifies competition in the GLP-1 weight-loss drug market.

CARPL.ai raises $10M led by IFC to expand its healthcare AI radiology platform globally.

DexCom is selected as the first participant in the FDA's TEMPO pilot program for digital health devices.

The White House launches a $5B AI initiative targeting drug discovery and chronic disease research.
GE HealthCare analyzes the push-pull between the costs and necessity of AI in medical imaging.

The FDA's commissioner seat may remain vacant for months, stalling the agency's long-term initiatives ahead of midterms.
Biotech companies are increasingly using AI across drug discovery, diagnostics, and clinical workflows.

OpenAI researcher Miles Wang leaves to start an AI drug discovery company.

Three drug makers commit billions to build AI infrastructure for drug discovery and development.

FDA expands its AI capabilities and completes consolidation of its data platform.
Natoe AI launches an AI-native teleradiology service for hospitals and imaging centers.

GE HealthCare CFO Jay Saccaro departs in a move the company described as surprising to investors.

AI-enabled discovery identifies a GLP-1 analogue without the gastrointestinal side effects of current drugs.
An unnamed small AI company presented at a major computing event, signaling the direction of AI-driven drug discovery.

Transcriptomics data analyzed by AI models is accelerating drug target discovery and candidate screening.

Trump admin appeals court ruling that struck down ACA rule changes on enrollment windows and eligibility checks.

BRICS nations collaborate on building digital health infrastructure to strengthen healthcare systems.

The US Senate begins consideration of a landmark bill regulating AI diagnostics, IVF, and emerging health technologies.

FDA grants 510(k) clearance to Velmeni's V4D 3D software for medical imaging.

UNITE selects its first digital health projects to pilot and scale.

CARPL.ai raises $10M in Series A led by IFC to expand its clinical AI platform for radiology.

CARPL.ai raises $10M in Series A funding.

DexCom lands the first slot in an FDA-CMS pilot program that incentivizes real-world data submission at scale.

Bioscan Research raises $1M for AI-powered brain injury detection technology.

Candid Health raises $120M in Series D for its AI-driven revenue cycle management platform.

CARPL.ai raises $10M led by IFC to expand its healthcare AI testing and deployment platform.

Prosper Medical raises $16M to build an AI-powered primary care platform.
Hanmi presents its AI drug-discovery platform used to develop a clinical-stage obesity drug at the ISMB conference.